Huntington's disease trials in Brazil

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

  Where

  Belo Horizonte, Campina Grande do Sul, Curitiba, Natal, Ribeirão Preto, Rio de Janeiro, São Paulo

  Age

  25 years and over

  People

  400 worldwide

  Run by

  Skyhawk Therapeutics, Inc.

  See details and how to joinNCT07378644 · EU 2025-522263-14-00